0.3136 USD
+0 (+1.16%)
0.315 USD
+0 (+0.45%)
ChartMill assigns a Buy % Consensus number of 82% to ADIL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.21. This target is 604.73% above the current price.
ADIL was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about ADIL.
In the previous month the buy percentage consensus was at a similar level.
ADIL was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-30 | Maxim Group | Upgrade | Hold -> Buy |
| 2024-11-14 | Rodman & Renshaw | Initiate | Buy |
| 2023-07-11 | Brookline Capital | Reiterate | Buy -> Buy |
| 2022-08-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-10-13 | Brookline Capital | Initiate | Buy |
| 2021-06-29 | Litchfield Hills | Initiate | Buy |
ADIAL PHARMACEUTICALS INC / ADIL FAQ
Can you provide the average price target for ADIAL PHARMACEUTICALS INC stock?
9 analysts have analysed ADIL and the average price target is 2.21 USD. This implies a price increase of 604.73% is expected in the next year compared to the current price of 0.3136.
What is the consensus rating for ADIL stock?
The consensus rating for ADIAL PHARMACEUTICALS INC (ADIL) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.